PPAR-α transcriptional activity is required to combat doxorubicin-induced podocyte injury in mice

Kidney International

Volumn 79, Issue 12, 2011, Pages 1274-1276

  Mori, Kiyoshi ^a   Mukoyama, Masashi ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; FENOFIBRATE; MITOCHONDRIAL DNA; NEPHRIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST;

ACUTE KIDNEY FAILURE; APOPTOSIS; CARDIOTOXICITY; DIABETIC NEPHROPATHY; DOWN REGULATION; DOXORUBICIN INDUCED NEPHROPATHY; DRUG INDUCED DISEASE; GENE; GLOMERULUS FILTRATION RATE; HEMATOLOGIC MALIGNANCY; HUMAN; HYPERTRIGLYCERIDEMIA; KIDNEY DISEASE; KNOCKOUT MOUSE; MITOCHONDRIAL DNA DEPLETION; NEPHROTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PRKDC GENE; PROTEIN EXPRESSION; PROTEINURIA; RENAL PROTECTION; REVIEW; SOLID TUMOR;

EID: 79957856737     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.36     Document Type: Note

References (10)

1. Shankland SJ . The podocyte's response to injury: role in proteinuria and glomerulosclerosis . Kidney Int 2006; 69:2131-2147. (Pubitemid 43882099)
2. Michalik L, Wahli W . Involvement of PPAR nuclear receptors in tissue injury and wound repair . J Clin Invest 2006;116: 598-606. (Pubitemid 43326864)
3. Hiukka A, Maranghi M, Matikainen N et al. PPARalpha: an emerging therapeutic target in diabetic microvascular damage . Nat Rev Endocrinol 2010; 6 : 454-463.
4. Li S, Nagothu KK, Desai V et al. Transgenic expression of proximal tubule peroxisome proliferator-activated receptor-alpha in mice confers protection during acute kidney injury . Kidney Int 2009;76: 1049-1062.
5. Papeta N, Zheng Z, Schon EA et al. Prkdc participates in mitochondrial genome maintenance and prevents adriamycin-induced nephropathy in mice . J Clin Invest 2010;120: 4055-4064.
6. Lin H, Hou CC, Cheng CF et al. Peroxisomal proliferator-activated receptor-alpha protects renal tubular cells from doxorubicin-induced apoptosis . M ol Pharmacol 2007;72: 1238-1245. (Pubitemid 350017443)
7. Zhou Y, Kong X, Zhao P et al. Peroxisome proliferator-activated receptor-is renoprotective in doxorubicin-induced glomerular injury . K idney Int 2011; 79: 1302-1311.
8. Park CW, Zhang Y, Zhang X et al. PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice . K idney Int 2006;69: 1511-1517.
9. Park CW, Kim HW, Ko SH et al. Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha . Diabetes 2006;55: 885-893.
10. Keech A, Simes RJ, Barter P et al. Effects of longterm fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial . Lancet 2005;366: 1849-1861.